Current organization of specialist pulmonary hypertension clinics: results of an international survey.

Abstract:

:Optimal pulmonary hypertension (PH) management relies on a timely, accurate diagnosis and follow-up in specialized clinics by multidisciplinary teams that have clearly defined responsibilities and protocols. Internationally agreed criteria for expert center staff are lacking, particularly with respect to nurses, who often act as a central component of the team. This survey aimed to evaluate the current organization of PH clinics and the role of nurses. The survey (35 questions) was online February-December 2015 and was advertised at international PH nurse meetings and through international PH organizations to their corresponding clinics. In total, 126 healthcare professionals from 32 countries responded. According to respondents, 54% of clinics managed >200 patients, of whom 49% had a pulmonary arterial hypertension (PAH) diagnosis, on average. In terms of staff, 66% had a dedicated program administrator, 35% had one full-time nurse coordinator/practitioner/specialist, and 57% had a nurse attend outpatient clinic alongside a physician. Crucially, not all centers had a nurse in their team. The role of a nurse coordinator/practitioner/specialist varied with 51% taking patient histories/examinations and 66% managing outpatients. In 34% of clinics, nurses were involved in their own research. Protocols were available for PH therapies (81%), management of heart failure (37%) and pain (26%), and referring patients who did not have PAH/chronic thromboembolic PH back to their specialist (62%). Not all clinics are meeting all of the standards outlined in the latest guidelines with key areas of improvement being level of support from/for nurses, clear protocols, and referral pathways.

journal_name

Pulm Circ

journal_title

Pulmonary circulation

authors

Doyle-Cox C,Nicholson G,Stewart T,Gin-Sing W

doi

10.1177/2045894019855611

subject

Has Abstract

pub_date

2019-04-01 00:00:00

pages

2045894019855611

issue

2

eissn

2045-8932

issn

2045-8940

journal_volume

9

pub_type

杂志文章
  • A prescribed walking regimen plus arginine supplementation improves function and quality of life for patients with pulmonary arterial hypertension: a pilot study.

    abstract::Current evidence suggests that exercise training is beneficial in pulmonary arterial hypertension (PAH). Unfortunately, the standard supervised, hospital-based programs limit patient accessibility to this important intervention. Our proof-of-concept study aimed to provide insight into the usefulness of a prescribed wa...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045893217743966

    authors: Brown MB,Kempf A,Collins CM,Long GM,Owens M,Gupta S,Hellman Y,Wong V,Farber M,Lahm T

    更新日期:2018-01-01 00:00:00

  • The genetics of pulmonary arterial hypertension in the post-BMPR2 era.

    abstract::Pulmonary arterial hypertension (PAH) is a rapidly progressive and fatal disease for which there is an ever-expanding body of genetic and related pathophysiological information on disease pathogenesis. The most common single culprit gene known is BMPR2, and animal models of the disease in several forms exist. There is...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.87293

    authors: Fessel JP,Loyd JE,Austin ED

    更新日期:2011-07-01 00:00:00

  • Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009.

    abstract::There are few data on the epidemiology of pulmonary hypertension (PH)-related hospitalizations in children in the United States. Our aim was to determine hospital mortality, length of hospitalization, and hospital charges pertaining to PH-related hospitalizations and also the effects of codiagnoses and comorbidities. ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/681226

    authors: Frank DB,Crystal MA,Morales DL,Gerald K,Hanna BD,Mallory GB Jr,Rossano JW

    更新日期:2015-06-01 00:00:00

  • Transforming growth factor-β inhibition and endothelin receptor blockade in rats with monocrotaline-induced pulmonary hypertension.

    abstract::Transforming growth factor-β (TGF-β) inhibition is an investigational therapy for pulmonary arterial hypertension with promising results in experimental studies. The present work compared this approach with endothelin-receptor blockade and evaluated the effects of combined administration. Pulmonary arterial hypertensi...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.105034

    authors: Megalou AJ,Glava C,Vilaeti AD,Oikonomidis DL,Baltogiannis GG,Papalois A,Vlahos AP,Kolettis TM

    更新日期:2012-10-01 00:00:00

  • Pulmonary arterial hypertension: Specialists' knowledge, practices, and attitudes of genetic counseling and genetic testing in the USA.

    abstract::Pulmonary arterial hypertension (PAH) is characterized by obstruction of pre-capillary pulmonary arteries, which leads to sustained elevation of pulmonary arterial pressure. Identifying those at risk through early interventions, such as genetic testing, may mitigate disease course. Current practice guidelines recommen...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045893217700156

    authors: Jacher JE,Martin LJ,Chung WK,Loyd JE,Nichols WC

    更新日期:2017-04-01 00:00:00

  • Significant intrapulmonary Schistosoma egg antigens are not present in schistosomiasis-associated pulmonary hypertension.

    abstract::Schistosomiasis-associated pulmonary arterial hypertension (PAH) is one of the most common causes of pulmonary hypertension worldwide. A potential contributing mechanism to the pathogenesis of this disease is a localized immune reaction to retained and persistent parasite-derived antigens. We sought to identify Schist...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.93544

    authors: Graham BB,Chabon J,Bandeira A,Espinheira L,Butrous G,Tuder RM

    更新日期:2011-10-01 00:00:00

  • Effects of exercise rehabilitation training on patients with pulmonary hypertension.

    abstract::Pulmonary hypertension (PH) comprises a group of pathophysiological syndromes characterized by elevated pulmonary artery pressure and pulmonary vascular resistance, which lead to right ventricular overload, and even right heart failure. PH has a poor prognosis and severely leads to a decline in quality of life. Histor...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.1177/2045894020937129

    authors: Zhang X,Xu D

    更新日期:2020-07-07 00:00:00

  • Congenital heart disease and pulmonary arterial hypertension in South America (2013 Grover Conference series).

    abstract::South America is a territory of 17,819,100 km(2), where ∼388 million people live in 13 countries. In the region, access to medical assistance (e.g., for treatment of cardiovascular disorders) is relatively easy in metropolitan areas but difficult in remote places such as the Andes and the Amazon. Altitudes up to ∼6,70...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.1086/676747

    authors: Lopes AA,Flores PC,Diaz GF,Mesquita SM

    更新日期:2014-09-01 00:00:00

  • Mechanical forces stimulate endothelial microparticle generation via caspase-dependent apoptosis-independent mechanism.

    abstract::Microparticle release by vascular endothelium has been implicated in various cardiovascular pathologies. Ventilator-induced lung injury (VILI) is a life-threatening complication of mechanical ventilation at high tidal volumes associated with excessive mechanical stretch of pulmonary vascular endothelial cells. However...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.109921

    authors: Vion AC,Birukova AA,Boulanger CM,Birukov KG

    更新日期:2013-01-01 00:00:00

  • Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension.

    abstract::Pulmonary hypertension is recognized as a leading cause of morbidity and mortality in patients with sickle cell disease (SCD). We now report benchtop phenotyping from the explanted lungs of the first successful lung transplant in SCD. Pulmonary artery smooth muscle cells (PASMCs) cultured from the explanted lungs were...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/674754

    authors: Rogers NM,Yao M,Sembrat J,George MP,Knupp H,Ross M,Sharifi-Sanjani M,Milosevic J,St Croix C,Rajkumar R,Frid MG,Hunter KS,Mazzaro L,Novelli EM,Stenmark KR,Gladwin MT,Ahmad F,Champion HC,Isenberg JS

    更新日期:2013-12-01 00:00:00

  • Levosimendan in pulmonary hypertension and right heart failure.

    abstract::Pulmonary hypertension is a multifactorial disease with a high morbidity and mortality. Right ventricular function is the most important predictor of morbidity and mortality in patients suffering from pulmonary hypertension, but currently there are no approved treatments directly supporting the failing right ventricle...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018790905

    authors: Hansen MS,Andersen A,Nielsen-Kudsk JE

    更新日期:2018-07-01 00:00:00

  • Idiopathic hypereosinophilic syndrome with pulmonary hypertension.

    abstract::Hypereosinophilic syndrome is a myeloproliferative disorder characterized by persistent eosinophilia with involvement of multiple organs. The occurrence of severe pulmonary hypertension (PH) in the setting of hypereosinophilic syndrome is very uncommon. A 43-year-old man with documented idiopathic hypereosinophlic syn...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1177/2045894018793999

    authors: Zhang L,Peng X,Adhikari BK,Li B,Liu Q,Mikeladze J,Zhang W

    更新日期:2019-01-01 00:00:00

  • Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series).

    abstract::Chronic lung disease (CLD), including pulmonary fibrosis (PF) and chronic obstructive pulmonary disease (COPD), is the fourth leading cause of mortality worldwide. Both are debilitating pathologies that impede overall tissue function. A common co-morbidity in CLD is vasculopathy, characterized by deregulated angiogene...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045893217739807

    authors: Kropski JA,Richmond BW,Gaskill CF,Foronjy RF,Majka SM

    更新日期:2018-01-01 00:00:00

  • Provider recognition and response to echocardiographic findings indicating pulmonary hypertension in the Veterans affairs medical center population.

    abstract::PH occurs alone or in association with many disorders. Many patients with transthoracic echocardiography (TTE) findings suggesting PH never receive additional evaluation. Patient characteristics and echocardiographic data associated with increased recognition of PH have not been fully evaluated. We evaluated TTE repor...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.4103/2045-8932.113184

    authors: Kingrey JF,Panos RJ,Ying J,Meganathan K,Vandivier R,Elwing JM

    更新日期:2013-04-01 00:00:00

  • Particulate matter disrupts human lung endothelial cell barrier integrity via Rho-dependent pathways.

    abstract::Increased exposure to ambient particulate matter (PM) is associated with elevated morbidity and mortality in patients with cardiopulmonary diseases and cancer. We and others have shown that PM induces lung microvascular barrier dysfunction which potentially enhances the systemic toxicity of PM. However, the mechanisms...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/689906

    authors: Wang T,Shimizu Y,Wu X,Kelly GT,Xu X,Wang L,Qian Z,Chen Y,Garcia JGN

    更新日期:2017-07-01 00:00:00

  • Molecular and functional significance of Ca(2+)-activated Cl(-) channels in pulmonary arterial smooth muscle.

    abstract::Increased peripheral resistance of small distal pulmonary arteries is a hallmark signature of pulmonary hypertension (PH) and is believed to be the consequence of enhanced vasoconstriction to agonists, thickening of the arterial wall due to remodeling, and increased thrombosis. The elevation in arterial tone in PH is ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.1086/680189

    authors: Leblanc N,Forrest AS,Ayon RJ,Wiwchar M,Angermann JE,Pritchard HA,Singer CA,Valencik ML,Britton F,Greenwood IA

    更新日期:2015-06-01 00:00:00

  • MicroRNA expression profile of pulmonary artery smooth muscle cells and the effect of let-7d in chronic thromboembolic pulmonary hypertension.

    abstract::Abstract Chronic thromboembolic pulmonary hypertension (CTEPH) is a life-threatening condition characterized by single or recurrent pulmonary thromboemboli, which promote pulmonary vascular remodeling. MicroRNA (miRNA), is a small, noncoding RNA that is involved in multiple cell processes and functions and may partici...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/674310

    authors: Wang L,Guo LJ,Liu J,Wang W,Yuan JX,Zhao L,Wang J,Wang C

    更新日期:2013-09-01 00:00:00

  • Effects of oxygen therapy in a pediatric normoxemic patient with pulmonary arterial hypertension and congenital heart disease.

    abstract::To shed light on the efficacy of oxygen therapy in pulmonary arterial hypertension (PAH) when hypoxemia is not present, we report seven years of observational data for a female patient recorded between February 2012 and February 2019 when she was aged 7.8-14.8 years. The patient was born with an atrial septal defect (...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894019845610

    authors: Green S,Stuart D

    更新日期:2019-04-01 00:00:00

  • Substrate stiffness-dependent exacerbation of endothelial permeability and inflammation: mechanisms and potential implications in ALI and PH (2017 Grover Conference Series).

    abstract::The maintenance of endothelial barrier integrity is absolutely essential to prevent the vascular leak associated with pneumonia, pulmonary edema resulting from inhalation of toxins, acute elevation to high altitude, traumatic and septic lung injury, acute lung injury (ALI), and its life-threatening complication, acute...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018773044

    authors: Karki P,Birukova AA

    更新日期:2018-04-01 00:00:00

  • Dosing characteristics of oral treprostinil in real-world clinical practice.

    abstract::Pharmacokinetic studies with oral treprostinil demonstrate that three times daily (TID) dosing reduces peak-to-trough plasma trepostinil fluctuations compared with twice daily (BID) dosing. TID dosing may allow for faster titration, higher total daily doses, and potentially improve the tolerability of oral trepostinil...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018770654

    authors: Balasubramanian VP,Messick CR,Broderick M,Nelsen AC

    更新日期:2018-04-01 00:00:00

  • Relationship of left ventricular outflow tract velocity time integral to treatment strategy in submassive and massive pulmonary embolism.

    abstract::Pulmonary embolism is associated with high rates of mortality and morbidity. It is important to understand direct comparisons of current interventions to differentiate favorable outcomes and complications. The objective of this study was to compare ultrasound-accelerated thrombolysis versus systemic thrombolysis versu...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894020953724

    authors: Antoine D,Chuich T,Mylvaganam R,Malaisrie C,Freed B,Cuttica M,Schimmel D Jr

    更新日期:2020-09-28 00:00:00

  • Non-invasive right ventricular load adaptability indices in patients with scleroderma-associated pulmonary arterial hypertension.

    abstract::Scleroderma-associated pulmonary arterial hypertension (SSc-PAH) is associated with worse outcome than idiopathic pulmonary arterial hypertension (IPAH), potentially due to worse right ventricular adaptation to load as suggested by pressure-volume loop analysis. The value of non-invasive load-adaptability metrics has ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894018788268

    authors: French S,Amsallem M,Ouazani N,Li S,Kudelko K,Zamanian RT,Haddad F,Chung L

    更新日期:2018-07-01 00:00:00

  • Understanding longitudinal biventricular structural and functional changes in a pulmonary hypertension Sugen-hypoxia rat model by cardiac magnetic resonance imaging.

    abstract::Cardiac magnetic resonance-derived ventricular variables are predictive of mortality in pulmonary arterial hypertension. Rodent models which emphasize ventricular function, allowing serial monitoring, are needed to identify pathophysiological features and novel therapies for pulmonary arterial hypertension. We investi...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894019897513

    authors: Jayasekera G,Wilson KS,Buist H,Woodward R,Uckan A,Hughes C,Nilsen M,Church AC,Johnson MK,Gallagher L,Mullin J,MacLean MR,Holmes WM,Peacock AJ,Welsh DJ

    更新日期:2020-02-10 00:00:00

  • Inactivation of carboxyl terminus of Hsc70-interacting protein prevents hypoxia-induced pulmonary arterial smooth muscle cells proliferation by reducing intracellular Ca2+ concentration.

    abstract::Carboxyl terminus of Hsc70-interacting protein (CHIP) is a 35-kDa cytoplasmic protein expressed in human striated muscle, brain, aortic smooth muscle, endothelial cells, and other tissues. Studies have confirmed that CHIP regulates cell growth, apoptosis, cell phenotype, metabolism, neurodegeneration, etc. However, wh...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894019875343

    authors: Dong F,Zhang J

    更新日期:2019-09-09 00:00:00

  • "Anagrelide-induced pulmonary arterial hypertension": a rare case of drug-induced pulmonary arterial hypertension.

    abstract::Pulmonary arterial hypertension can be associated with exposure to certain drugs or toxins. However, only a few cases of drug-induced pulmonary arterial hypertension have been previously reported. Anagrelide is an oral imidazoquinazoline agent that is prescribed for reducing elevated platelet counts in patients with m...

    journal_title:Pulmonary circulation

    pub_type:

    doi:10.1177/2045894019896682

    authors: Sumimoto K,Taniguchi Y,Matsuoka Y,Onishi H,Emoto N,Hirata KI

    更新日期:2019-12-27 00:00:00

  • Erratum.

    abstract::[This corrects the article DOI: 10.1086/688060.]. ...

    journal_title:Pulmonary circulation

    pub_type: 已发布勘误

    doi:10.1086/689215

    authors:

    更新日期:2016-12-01 00:00:00

  • Neonatal oxygenation, pulmonary hypertension, and evolutionary adaptation to high altitude (2013 Grover Conference series).

    abstract::Andeans and Tibetans have less altitude reduction in birth weight than do shorter-resident groups, but only Tibetans are protected from pulmonary hypertension and chronic mountain sickness (CMS). We hypothesized that differences in neonatal oxygenation were involved, with arterial O2 saturation (SaO2) being highest in...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.1086/679719

    authors: Niermeyer S,Andrade-M MP,Vargas E,Moore LG

    更新日期:2015-03-01 00:00:00

  • Effects of tetrahydrobiopterin oral treatment in hypoxia-induced pulmonary hypertension in rat.

    abstract::Endothelial nitric oxide synthase (eNOS) plays a major role in maintaining pulmonary vascular homeostasis. Tetrahydrobiopterin (BH4), an essential cofactor that stabilizes the dimerization of eNOS and balances nitric oxide (NO) and superoxide production, may have therapeutic potential in pulmonary hypertension. In the...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1086/677361

    authors: Francis BN,Hale A,Channon KM,Wilkins MR,Zhao L

    更新日期:2014-09-01 00:00:00

  • EXPRESS: Left ventricular early diastolic strain rate detected by two-dimensional speckle tracking echocardiography and disease severity in pre-capillary pulmonary hypertension.

    abstract:: ...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章

    doi:10.1177/2045894019865158

    authors: Liu BY,Wu WC,Zeng QX,Liu ZH,Tian Y,Niu LL,Cheng XL,Luo Q,Zhao Z,An CH,Huang L,Wang H,He J,Xiong CM

    更新日期:2019-07-03 00:00:00

  • Gender, sex hormones and pulmonary hypertension.

    abstract::Most subtypes of pulmonary arterial hypertension (PAH) are characterized by a greater susceptibility to disease among females, although females with PAH appear to live longer after diagnosis. While this "estrogen paradoxȍ of enhanced female survival despite increased female susceptibility remains a mystery, recent pro...

    journal_title:Pulmonary circulation

    pub_type: 杂志文章,评审

    doi:10.4103/2045-8932.114756

    authors: Austin ED,Lahm T,West J,Tofovic SP,Johansen AK,Maclean MR,Alzoubi A,Oka M

    更新日期:2013-04-01 00:00:00